The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Impact of Biosimilars on Oncology

Sue Naeyaert,
Published Online:11:22 PM, Fri May 20, 2016


Sue Naeyaert, senior director of Biosimilars Policy, EMD Serono, discusses the long-term impact that biosimilars could potentially have on the field of oncology.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.